Edwards Lifesciences Corp - 8-K Filing
Edwards Lifesciences reports Q2 revenue of $1.74B with TAVR sales up 11.3% and raises full-year guidance (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $EW